Articles on lenacapavir
Displaying all articles
Targeting men who move around for work is crucial for the success of a new HIV/Aids treatment.
Long-lasting HIV drug could help people who can’t take daily PrEP pills.
Africa’s investment into research and development is far below the global average.
Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles that remain.
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV prevention.
HIV prevention and treatment have made great strides, but barriers created by stigma, laws and logistics remain.
A breakthrough drug is a significant step forward in the fight against HIV. But without changes in behaviour, infection rates won’t come down.






